2.89
Schlusskurs vom Vortag:
$3.04
Offen:
$2.97
24-Stunden-Volumen:
57,875
Relative Volume:
0.59
Marktkapitalisierung:
$7.12M
Einnahmen:
$77,900
Nettoeinkommen (Verlust:
$-8.05M
KGV:
-0.3131
EPS:
-9.2296
Netto-Cashflow:
$-7.47M
1W Leistung:
-1.70%
1M Leistung:
-9.97%
6M Leistung:
-51.75%
1J Leistung:
-59.35%
Aclarion Inc Stock (ACON) Company Profile
Firmenname
Aclarion Inc
Sektor
Branche
Telefon
833 275 2266
Adresse
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ACON
Aclarion Inc
|
2.89 | 7.12M | 77,900 | -8.05M | -7.47M | -9.2296 |
|
VEEV
Veeva Systems Inc
|
159.71 | 25.94B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
66.84 | 13.12B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
48.61 | 8.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
84.92 | 7.10B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
HNGE
Hinge Health Inc
|
70.38 | 5.45B | 646.34M | -512.40M | 202.76M | -6.6871 |
Aclarion Inc Aktie (ACON) Neueste Nachrichten
Aclarion Inc (ACONW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aclarion (ACON) upgraded to buy: Here's why - MSN
Aclarion Inc (ACONW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aclarion Inc (ACONW) Institutional Confidence - TradingKey
Aclarion Inc (ACONW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aclarion Inc (ACONW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aclarion Inc (ACONW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aclarion Inc (ACONW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aclarion Inc (ACONW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aclarion Inc (ACONW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aclarion Inc (ACON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aclarion Inc (ACON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aclarion Inc (ACON) Institutional Confidence - TradingKey
Aclarion Inc (ACON) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aclarion Inc (ACON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aclarion Inc (ACON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aclarion Inc (ACON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aclarion Inc (ACON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aclarion Inc (ACON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aclarion board rejects Echo Lake’s $4 per share takeover bid By Investing.com - Investing.com Nigeria
Aclarion Inc. (ACON) Q1 2026 Earnings: EPS Surpasses Estimates Despite Ongoing Revenue AbsenceEarnings Season Outlook - newsline.com
Aclarion Inc. (ACON) Slides Amid Light Trading, Support at $2.96 in FocusTRIN Signal - newsline.com
Aclarion (ACON) Chief Strategy Officer granted 55,000 RSUs vesting in 2027 - Stock Titan
Aclarion (ACON) director receives 20,000 RSUs vesting in 2027 - Stock Titan
Aclarion (NASDAQ: ACON) director receives 20,000 RSU equity grant - Stock Titan
Aclarion (ACON) CFO awarded 50,000 restricted stock units set to vest 2027 - Stock Titan
Aclarion (ACON) CEO Brent Ness receives 100,000 RSU equity award - Stock Titan
Aclarion (ACON) director awarded 20,000 RSUs vesting in 2027 - Stock Titan
Aclarion (ACON) grants 100,000 RSUs to Executive Chairman Thramann - Stock Titan
Aclarion (ACON) director receives 20,000 RSU equity award, total holdings 22,502 shares - Stock Titan
Director granted 20,000 RSUs at Aclarion (NASDAQ: ACON) vesting 2027 - Stock Titan
ACON Q1 2026 Earnings: EPS Beats Estimates Despite No Revenue ReportedMargin Expansion Trends - newsline.com
ACONW Warrants Surge Over 10%: A Closer Look at the Microcap MoveValue Area High - newsline.com
Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform - Ortho Spine News
Aclarion Inc. (ACON) Consolidates Near Key Support After Marginal DeclinePrice Target - newsline.com
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub - The Manila Times
Triple-digit Nociscan growth as Aclarion presents back-pain tech in Vegas - Stock Titan
Aclarion Company Profile & Introduction - Moomoo
Aclarion partners with PRIA Healthcare on market access program By Investing.com - Investing.com South Africa
Aclarion partners with PRIA Healthcare on market access program - Investing.com
Aclarion enlists PRIA in push for insurer coverage of AI back-pain scans - Stock Titan
Aclarion Inc. Q1 2026 Earnings: EPS Surprises to the Upside Amid Cost DisciplineReturn On Capital - newsline.com
Aclarion waves off investor’s acquisition offer - BizWest
Echo Lake Capital cancelled the acquisition of Aclarion, Inc.. - marketscreener.com
Aclarion Comments on Echo Lake News - Baystreet.ca
ACON Q1 2026 Earnings: Narrower Loss Beats Estimates, Shares Edge HigherShare Repurchase Impact - newsline.com
Aclarion board rejects Echo Lake’s $4 per share takeover bid - Investing.com
Aclarion Rejects Echo Lake Capital’S Unsolicited Acquisition Proposal - TradingView
Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal - The Manila Times
Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting - The Manila Times
Aclarion board: Echo Lake’s $4 bid uses company cash, favors buyer - Stock Titan
Finanzdaten der Aclarion Inc-Aktie (ACON)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):